Patient info

L01XH Histone deacetylase (HDAC) inhibitors

ATC group of level 4 – chemical subgroup · in plain English: cancer medicines

This site has the patient leaflet or the SPC of 3 medicines in this group and its subgroups.

Active substance: Panobinostat – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01X Other antineoplastic agents 225 medicines
        1. L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
          1. L01XH03 panobinostat 3 medicines

4 more subgroups have no medicine with a leaflet on this site.

Medicines in the group and its subgroups

MedicineLegal category
Farydak 10 mg hard capsule SPC (L01XH03 panobinostat) Prescription only (POM)
Farydak 15 mg hard capsule SPC (L01XH03 panobinostat) Prescription only (POM)
Farydak 20 mg hard capsule SPC (L01XH03 panobinostat) Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01XH

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.